Clinically significant cancer was detected in 29.2 versus 29.6 percent of men with biparametric and multiparametric MRI.
News Medical on MSN
ASTRO: Targeted radioactive therapy for recurrent prostate cancer, new SBRT approaches, 5DCT-guided imaging advances and more
Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will share the latest research and clinical trial results at the 2025 American Society for Radiation Oncology (ASTRO) ...
This guide to MRI for kids helps parents and caregivers understand what to expect during a Magnetic Resonance Imaging (MRI) ...
Until about 15 years ago, most men diagnosed with prostate cancer — no matter how aggressive — underwent surgery or radiation ...
The TULSA procedure is integral to our practice because it offers many men effective prostate treatment without the life-altering side effects of surgery — such as incontinence or erectile dysfunction ...
Dr. Lilach O. Lerman's Renovascular Research Lab at Mayo Clinic studies functional MRI and other imaging to assess renal and cardiac hemodynamics and renal fibrosis.
VCU Massey Comprehensive Cancer Center continues to lead the way with MRI-guided radiation therapy, now in prostate cancer ...
Profound Medical ( ($TSE:PRN) ) just unveiled an announcement. Profound Medical Corp. announced the launch of a pioneering TULSA program by Texas ...
Prostate cancer stages explain how far cancer has spread. Stage 1 and 2 stay in the prostate and are highly treatable. Stage 3 spreads to nearby tissues, while stage 4 reaches distant organs. PSA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback